Literature DB >> 11734640

Dimer formation drives the activation of the cell death protease caspase 9.

M Renatus1, H R Stennicke, F L Scott, R C Liddington, G S Salvesen.   

Abstract

A critical step in the induction of apoptosis is the activation of the apoptotic initiator caspase 9. We show that at its normal physiological concentration, caspase 9 is primarily an inactive monomer (zymogen), and that activity is associated with a dimeric species. At the high concentrations used for crystal formation, caspase 9 is dimeric, and the structure reveals two very different active-site conformations within each dimer. One site closely resembles the catalytically competent sites of other caspases, whereas in the second, expulsion of the "activation loop" disrupts the catalytic machinery. We propose that the inactive domain resembles monomeric caspase 9. Activation is induced by dimerization, with interactions at the dimer interface promoting reorientation of the activation loop. These observations support a model in which recruitment by Apaf-1 creates high local concentrations of caspase 9 to provide a pathway for dimer-induced activation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734640      PMCID: PMC64668          DOI: 10.1073/pnas.231465798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

2.  The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis.

Authors:  H Blanchard; L Kodandapani; P R Mittl; S D Marco; J F Krebs; J C Wu; K J Tomaselli; M G Grütter
Journal:  Structure       Date:  1999-09-15       Impact factor: 5.006

Review 3.  Caspase activation: the induced-proximity model.

Authors:  G S Salvesen; V M Dixit
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Allosteric regulation of the cofactor-dependent serine protease coagulation factor VIIa.

Authors:  W Ruf; C D Dickinson
Journal:  Trends Cardiovasc Med       Date:  1998-11       Impact factor: 6.677

5.  The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity.

Authors:  Y Wei; T Fox; S P Chambers; J Sintchak; J T Coll; J M Golec; L Swenson; K P Wilson; P S Charifson
Journal:  Chem Biol       Date:  2000-06

6.  Caspase-9 can be activated without proteolytic processing.

Authors:  H R Stennicke; Q L Deveraux; E W Humke; J C Reed; V M Dixit; G S Salvesen
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

7.  Stability and oligomeric equilibria of refolded interleukin-1beta converting enzyme.

Authors:  R V Talanian; L C Dang; C R Ferenz; M C Hackett; J A Mankovich; J P Welch; W W Wong; K D Brady
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

Review 8.  An active zymogen: unravelling the mystery of tissue-type plasminogen activator.

Authors:  M T Stubbs; M Renatus; W Bode
Journal:  Biol Chem       Date:  1998-02       Impact factor: 3.915

Review 9.  The clot thickens: clues provided by thrombin structure.

Authors:  M T Stubbs; W Bode
Journal:  Trends Biochem Sci       Date:  1995-01       Impact factor: 13.807

10.  Differential requirement for caspase 9 in apoptotic pathways in vivo.

Authors:  R Hakem; A Hakem; G S Duncan; J T Henderson; M Woo; M S Soengas; A Elia; J L de la Pompa; D Kagi; W Khoo; J Potter; R Yoshida; S A Kaufman; S W Lowe; J M Penninger; T W Mak
Journal:  Cell       Date:  1998-08-07       Impact factor: 41.582

View more
  139 in total

1.  Oligomerization and activation of caspase-9, induced by Apaf-1 CARD.

Authors:  Eric N Shiozaki; Jijie Chai; Yigong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  The structure of procaspase 6 is similar to that of active mature caspase 6.

Authors:  Byoung Heon Kang; Eunsil Ko; Oh-Keun Kwon; Kwan Yong Choi
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

3.  Caspase-9 holoenzyme is a specific and optimal procaspase-3 processing machine.

Authors:  Qian Yin; Hyun Ho Park; Jee Y Chung; Su-Chang Lin; Yu-Chih Lo; Li S da Graca; Xuejun Jiang; Hao Wu
Journal:  Mol Cell       Date:  2006-04-21       Impact factor: 17.970

Review 4.  Caspase activation, inhibition, and reactivation: a mechanistic view.

Authors:  Yigong Shi
Journal:  Protein Sci       Date:  2004-08       Impact factor: 6.725

5.  Controlling TRAIL-mediated caspase-3 activation.

Authors:  O Micheau; D Mérino
Journal:  Leukemia       Date:  2004-10       Impact factor: 11.528

Review 6.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

7.  The BIR domain of IAP-like protein 2 is conformationally unstable: implications for caspase inhibition.

Authors:  Hwain Shin; Martin Renatus; Brendan P Eckelman; Viviane A Nunes; Claudio A M Sampaio; Guy S Salvesen
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

8.  Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

Authors:  Domagoj Vucic; Matthew C Franklin; Heidi J A Wallweber; Kanad Das; Brendan P Eckelman; Hwain Shin; Linda O Elliott; Saloumeh Kadkhodayan; Kurt Deshayes; Guy S Salvesen; Wayne J Fairbrother
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

9.  Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells.

Authors:  Manabu Kurokawa; Takahiro Ito; Chih-Sheng Yang; Chen Zhao; Andrew N Macintyre; David A Rizzieri; Jeffrey C Rathmell; Michael W Deininger; Tannishtha Reya; Sally Kornbluth
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-16       Impact factor: 11.205

10.  pH effects on the stability and dimerization of procaspase-3.

Authors:  Kakoli Bose; A Clay Clark
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.